Trials / Completed
CompletedNCT00311870
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (planned)
- Sponsor
- Steno Diabetes Center Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to compare the renoprotective effect of a long acting calcium antagonist (nisoldipine) with an angiotensin converting enzyme inhibitor (lisinopril)in type 1 diabetic patients with diabetic kidney disease. In total, 51 patients were randomised to treatment with one of these drugs for 4 years. Changes in kidney function, blood pressure and urinary excretion of albumin were measured every 6 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nisoldipine | |
| DRUG | lisinopril |
Timeline
- Start date
- 1993-03-01
- Completion
- 1999-04-01
- First posted
- 2006-04-06
- Last updated
- 2006-04-06
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00311870. Inclusion in this directory is not an endorsement.